Tandem Diabetes (TNDM) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street mostly rises as Fed holds key rate steady, deferring next likely hike to December
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- Oracle sets $225 billion revenue target for FY30 at investor day
- S&P Global explores potential separation of Capital IQ business
- SpaceX stock drops amid spaceport lawsuit, debt concerns
- Rivian shares slip ahead of Thursday earnings release
- Moderna stock rises on latest cancer vaccine data publication
Tandem Diabetes Care Reports First Quarter 2016 Financial Results and Updates 2016 Guidance
April 28, 2016 4:20 PM EDTSAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:slim G4 and t:flex® Insulin Pumps, today reported its financial results for the quarter ended March 31, 2016 and updated its financial guidance for the year ending December 31, 2016.
First Quarter 2016 Summary
In comparing the first quarter of 2016 to the same period of 2015:
Sales grew 63 percent to $20.1 million from $12.3 million Pump shipments grew 63 percent to 4,042 pumps from 2,487 pumps Operating margin improved to negative... More


